Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus (Q44750611)

5 December 2017

title

Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus (English)

1 reference

5 December 2017

0 references

Bacigalupo A

1

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Bone Marrow Transplantation

5 December 2017

published in

1 reference

5 December 2017

volume

33

1 reference

5 December 2017

issue

7

1 reference

5 December 2017

page(s)

691-696

1 reference

Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT).

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

7 January 2021

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

7 January 2021

Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

7 January 2021

One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and beta-thalassaemia major: potential cure of both marrow disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704416

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704416

1 reference

5 December 2017

1 reference